Antonia V. Bennett

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment	2022	Gita Thanarajasingam Ethan Basch Carolyn Mead‐Harvey Antonia V. Bennett Gina L. Mazza Gisela Schwab Jessica Roydhouse Lauren J. Rogak Amylou C. Dueck
+ PDF Chat	SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials	2021	Melanie Calvert Madeleine King Rebecca Mercieca‐Bebber Olalekan Lee Aiyegbusi Derek Kyte Anita Slade An‐Wen Chan Ethan Basch Jill A. Bell Antonia V. Bennett
+	Applying patient-reported outcome methodology to capture patient-reported health data: Report from an NIH Collaboratory roundtable	2020	Antonia V. Bennett Mattias Jönsson Ronald C. Chen Sana M. Al ‐Khatib Kevin P. Weinfurt Lesley H. Curtis
+	Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.	2020	Amylou C. Dueck Claus Becker Lauren J. Rogak Deborah Schrag Bryce B. Reeve Patricia A. Spears Mary Lou Smith Mrinal M. Gounder Michelle R. Mahoney Gary K. Schwartz
+ PDF Chat	Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial	2019	Amylou C. Dueck Howard I. Scher Antonia V. Bennett Gina L. Mazza Gita Thanarajasingam Gisela Schwab Aaron Weitzman Lauren J. Rogak Ethan Basch
+ PDF Chat	Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial	2019	Amylou C. Dueck Howard I. Scher Antonia V. Bennett Gina L. Mazza Gita Thanarajasingam Gisela Schwab Aaron Weitzman Lauren J. Rogak Ethan Basch
+ PDF Chat	Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events	2018	Thomas M. Atkinson Bryce B. Reeve Amylou C. Dueck Antonia V. Bennett Tito R. Mendoza Lauren J. Rogak Ethan Basch Yuelin Li
+ PDF Chat	Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting	2017	Thomas M. Atkinson Lauren J. Rogak Narre Heon Sean J. Ryan Mary Shaw Liora P. Stark Antonia V. Bennett Ethan Basch Yuelin Li
+ PDF Chat	The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review	2016	Thomas M. Atkinson Sean J. Ryan Antonia V. Bennett Angela M. Stover Rebecca M. Saracino Lauren J. Rogak Sarah Jewell Konstantina Matsoukas Yuelin Li Ethan Basch
+ PDF Chat	The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review	2016	Thomas M. Atkinson Sean J. Ryan Antonia V. Bennett Angela M. Stover Rebecca M. Saracino Lauren J. Rogak Sarah Jewell Konstantina Matsoukas Yuelin Li Ethan Basch
+ PDF Chat	Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial	2016	Ethan Basch William A. Wood Deborah Schrag Camelia S. Sima Mary Shaw Lauren J. Rogak Mark G. Kris Marwan Shouery Antonia V. Bennett Thomas M. Atkinson
+ PDF Chat	The Project Data Sphere Initiative: Accelerating Cancer Research by Sharing Data	2015	Angela K. Green Katherine E. Reeder‐Hayes Robert W. Corty Ethan Basch Mathew I. Milowsky Stacie B. Dusetzina Antonia V. Bennett William A. Wood
+	PRO Data Collection in Clinical Trials Using Mixed Modes: Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force	2014	Sonya Eremenco Stephen Joel Coons Jean Paty Karin S. Coyne Antonia V. Bennett Damian McEntegart

Common Coauthors

Coauthor	Papers Together
Ethan Basch	11
Lauren J. Rogak	9
Thomas M. Atkinson	6
Amylou C. Dueck	6
Gita Thanarajasingam	4
Gisela Schwab	4
Yuelin Li	4
Gina L. Mazza	3
Sean J. Ryan	3
Angela M. Stover	2
Sarah Jewell	2
William A. Wood	2
Rebecca M. Saracino	2
Deborah Schrag	2
Aaron Weitzman	2
Mary Shaw	2
Tito R. Mendoza	2
Howard I. Scher	2
Bryce B. Reeve	2
Konstantina Matsoukas	2
Ingolf Griebsch	1
Robert W. Corty	1
Mrinal M. Gounder	1
Robert Golub	1
Amanda Hunn	1
Carolyn Mead‐Harvey	1
Mark G. Kris	1
Daniel O’Connor	1
Galina Velikova	1
Stacie B. Dusetzina	1
Derek Kyte	1
Katherine E. Reeder‐Hayes	1
Anita Slade	1
Bellinda L. King‐Kallimanis	1
Antoine Regnault	1
Marwan Shouery	1
Kirstie Haywood	1
Stephen Joel Coons	1
An‐Wen Chan	1
Jean Paty	1
Lori Frank	1
Anita Walker	1
Donald L. Patrick	1
Ameeta Retzer	1
Kevin P. Weinfurt	1
Jane Blazeby	1
Karin S. Coyne	1
Lisa Campbell	1
Dennis A. Revicki	1
Grace Turner	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force Report	2008	Stephen Joel Coons Chad Gwaltney Ron D. Hays J. Jason Lundy Jeff A. Sloan Dennis A. Revicki William R. Lenderking David Cella Ethan Basch	2
+ PDF Chat	Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance	2006		2
+	Equivalence of Electronic and Paper-and-Pencil Administration of Patient-Reported Outcome Measures: A Meta-Analytic Review	2007	Chad Gwaltney Alan L. Shields Saul Shiffman	2
+ PDF Chat	Method of administration of PROMIS scales did not significantly impact score level, reliability, or validity	2013	Jakob Bue Bjørner Matthias Rose Barbara Gandek Arthur A. Stone Doerte U. Junghaenel John E. Ware	1
+ PDF Chat	Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies	2009	Fujian Song Sheetal Parekh‐Bhurke Lee Hooper Yoon K. Loke Jon J Ryder Alex J. Sutton Caroline Hing Ian Harvey	1
+	Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials	1998	Diane L. Fairclough Harriet F. Peterson David Cella P. Bonomi	1
+ PDF Chat	Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials	2014	Stephen Joel Coons Sonya Eremenco J. Jason Lundy Paul O’Donohoe Hannah O’Gorman William Malizia	1
+	Pooling of cross-cultural PRO data in multinational clinical trials: How much can poor measurement affect statistical power?	2014	Antoine Regnault Jean-François Hamel Donald L. Patrick	1
+	PRO Data Collection in Clinical Trials Using Mixed Modes: Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force	2014	Sonya Eremenco Stephen Joel Coons Jean Paty Karin S. Coyne Antonia V. Bennett Damian McEntegart	1
+ PDF Chat	Clinical Trials: Discerning Hype From Substance	2010	Thomas R. Fleming	1
+	Incomplete Data in Randomized Dermatology Trials: Consequences and Statistical Methodology	2013	Michael A. McIsaac Richard J. Cook Melanie Poulin-Costello	1
+	Patient-Reported Outcomes to Support Medical Product Labeling Claims: FDA Perspective	2007	Donald L. Patrick Laurie B. Burke John H. Powers Jane Scott Edwin P. Rock Sahar Dawisha Robert T. O’Neill Dianne L. Kennedy	1
+ PDF Chat	Imputation by the mean score should be avoided when validating a Patient Reported Outcomes questionnaire by a Rasch model in presence of informative missing data	2011	Jean-Benoît Hardouin Ronán Conroy Véronique Sébille	1
+	Analysis and Interpretation of Results Based on Patient-Reported Outcomes	2007	Jeff A. Sloan Amylou C. Dueck Pennifer Erickson Harry A. Guess Dennis A. Revicki Nancy C. Santanello	1
+ PDF Chat	Handling missing data in RCTs; a review of the top medical journals	2014	Melanie L. Bell Mallorie H. Fiero Nicholas J. Horton Chiu‐Hsieh Hsu	1
+ PDF Chat	Consistency of Phase III Clinical Trial Abstracts Presented at an Annual Meeting of the American Society of Clinical Oncology Compared With Their Subsequent Full-Text Publications	2008	Vincent C. Tam Sébastien J. Hotte	1
+	Integration of patient-reported outcomes in multiregional confirmatory clinical trials	2013	Ari Gnanasakthy Carla DeMuro Caroline Boulton	1
+	The Mayo Clinic Manuscript Series Relative to the Discussion, Dissemination, and Operationalization of the Food and Drug Administration Guidance on Patient-Reported Outcomes	2007	Jeff A. Sloan Michele Y. Halyard Marlene H. Frost Amylou C. Dueck Bonnie Teschendorf Margaret Rothman	1
+ PDF Chat	Survival End Point Reporting in Randomized Cancer Clinical Trials: A Review of Major Journals	2008	Simone Mathoulin‐Pélissier S. Gourgou-Bourgade Franck Bonnetain Andrew Kramar	1
+	Asking Sensitive Questions: The Impact of Data Collection Mode, Question Format, and Question Context	1996	Roger Tourangeau Tom Smith	1
+	How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30	2004	Erik K. Fromme Kristine M. Eilers Motomi Mori Yi‐Ching Hsieh Tomasz M. Beer	1
+ PDF Chat	The design and conduct of clinical trials to limit missing data	2012	Roderick J. A. Little Matthew L. Cohen Kay Dickersin Scott S. Emerson John T. Farrar James D. Neaton Weichung Joe Shih Jay P. Siegel Hal S. Stern	1
+ PDF Chat	SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials	2013	An‐Wen Chan Jennifer Tetzlaff Douglas G. Altman Andreas Laupacis Peter C Gøtzsche Karmela Krleža-Jerić Asbjørn Hróbjartsson Howard Mann Kay Dickersin Jesse A. Berlin	1
+	Toxicity grading systems	1994	H. Franklin Giovanni Simonetti Anne-Charlotte Dubbelman W W ten Bokkel Huinink Babs G. Taal Gea Wigbout Ingrid A.M. Mandjes Otilia Dalesio N.K. Aaronson	1
+	Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach	1988	Elizabeth R. DeLong David M. DeLong Daniel L. Clarke‐Pearson	1
+	Toward a Patient-Centered Value Framework in Oncology	2016	Ethan Basch	1
+	Quality of Life at Baseline	1998	Maria M. Brooks Louise S. Jenkins Eleanor Schron Jonathan S. Steinberg Jean A. Cross David S. Paeth	1
+ PDF Chat	Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)	2016	Paul G. Kluetz Diana T. Chingos Ethan Basch Sandra A. Mitchell	1
+	A predictive model for aggressive non-Hodgkin's lymphoma	1993	Margaret A. Shipp David P. Harrington J R Anderson Jamés O. Armitage Gianni Bonadonna G. Brittinger Fernando Cabanillas George P. Canellos Bertrand Coiffier Joseph M. Connors	1
+ PDF Chat	Validity and usefulness of a single‐item measure of patient‐reported bother from side effects of cancer therapy	2017	Timothy Pearman Jennifer L. Beaumont Daniel K. Mroczek M. O'Connor David Cella	1
+ PDF Chat	Guidelines for the Content of Statistical Analysis Plans in Clinical Trials	2017	Carrol Gamble Ashma Krishan Deborah Stocken Steff Lewis Edmund Juszczak Caroline J Doré Paula Williamson Douglas G. Altman Alan Montgomery Pilar Lim	1
+ PDF Chat	Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016	2018	Laura Marandino Anna La Salvia Cristina Sonetto Emmanuele De Luca Daniele Pignataro Clizia Zichi Rosario Francesco Di Stefano Eleonora Ghisoni Pasquale Lombardi Annapaola Mariniello	1
+ PDF Chat	The importance of patient-reported outcomes in clinical trials and strategies for future optimization	2018	Rebecca Mercieca‐Bebber Madeleine King Melanie Calvert Martin R. Stockler Michael Friedlander	1
+	Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018	2019	Laura Marandino Emmanuele De Luca Clizia Zichi Pasquale Lombardi Maria Lucia Reale Daniele Pignataro Rosario Francesco Di Stefano Eleonora Ghisoni Annapaola Mariniello Elena Trevisi	1
+ PDF Chat	Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial	2019	Amylou C. Dueck Howard I. Scher Antonia V. Bennett Gina L. Mazza Gita Thanarajasingam Gisela Schwab Aaron Weitzman Lauren J. Rogak Ethan Basch	1
+	US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017	2019	Mallorie H. Fiero Jessica Roydhouse Jonathon Vallejo Bellinda L. King‐Kallimanis Paul G. Kluetz Rajeshwari Sridhara	1
+ PDF Chat	Design and analytic considerations for using patient-reported health data in pragmatic clinical trials: report from an NIH Collaboratory roundtable	2019	Frank W. Rockhold Jessica D. Tenenbaum Rachel Richesson Keith Marsolo Emily C. O’Brien	1
+ PDF Chat	A Predictive Model for Aggressive Non-Hodgkin's Lymphoma	1993		1
+	Design and Analysis of Quality of Life Studies in Clinical Trials	2002	Diane L. Fairclough	1
+	Wiley Encyclopedia of Clinical Trials	2006	Ralph B. D’Agostino Lisa Sullivan Joseph M. Massaro	1
+	Treatment‐by‐Center Interaction	2014	Paul Gallo	1
+ PDF Chat	Increasing value and reducing waste in research design, conduct, and analysis	2014	John P. A. Ioannidis Sander Greenland Mark A. Hlatky Muin J. Khoury Malcolm Macleod David Moher Kenneth F. Schulz Robert Tibshirani	1